[Form 4] Immunic, Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

4

07/18/2025 - 04:06 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Immunic Inc

NASDAQ:IMUX

IMUX Rankings

#4911 Ranked by Market Cap

N/A Ranked by Dividends

IMUX Latest News

Oct 1, 2025

Immunic to Participate in Scientific and Investor Conferences in October

Sep 25, 2025

Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis

Sep 9, 2025

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis

Sep 4, 2025

Immunic to Participate in Investor and Scientific Conferences in September

Aug 7, 2025

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

IMUX Latest SEC Filings

Sep 25, 2025

[8-K] IMMUNIC, INC. Reports Material Event

Aug 27, 2025

[S-8] Immunic, Inc. Employee Benefit Plan Registration

Aug 14, 2025

[SCHEDULE 13G] Immunic, Inc. SEC Filing

Aug 14, 2025

[SCHEDULE 13G] Immunic, Inc. SEC Filing

Aug 14, 2025

[SCHEDULE 13G/A] Immunic, Inc. SEC Filing

IMUX Stock Data

Market Cap 95.03M

Float 97.35M

Insiders Ownership 1.31%

Institutions Ownership 53.6%

Short Percent 9.97%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City NEW YORK